$APO

Kelly Martin sold $423K of APO

Kelly Martin (Chief Financial Officer) sold 3,000 shares of Apollo Global Management, Inc. (APO) at $140.84 ($0.42M total) on 2026-08-14.

Original reporting
SEC EDGAR · Kelly Martin
Published Aug 17, 2026, 10:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 10:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$APO
Neutral
high confidence
Mentioned
$APO
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$APONeutralLow
01

Why it matters

The newest fact is the disclosed sale size, price, and post-transaction holdings. It is not a corporate action, earnings release, or regulatory event.

02

Market read

Traders may note the insider sale, but there is no fundamental catalyst in the text to drive a directional repricing.

03

What to watch

The article does not state whether the sale was part of a broader pattern, nor does it include any accompanying buy transactions or company-specific news.

Relevance 4/10Novelty 2/10Timing: filed 2026-08-17, transaction dated 2026-08-14

Background

This is an SEC Form 4 insider transaction disclosure for Apollo Global Management, Inc., reported by CFO Kelly Martin.

Company-level read

Ticker impact

$APONeutralHigh confidence
Context

Apollo CFO Kelly Martin filed a Form 4 showing an open-market sale of 3,000 shares at $140.8450 on 2026-08-14.

Expected impact

Likely limited near-term impact; treat as routine insider activity unless paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and this transaction is explicitly an open-market sale with no 10b5-1 plan stated, but the article contains no additional earnings, legal, or operational catalyst.

Market effects

No clear sector read-through from a single routine insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can sometimes signal reduced personal conviction, but this filing alone lacks context (tax, diversification, liquidity needs).

Key entities

  • Apollo Global Management, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Kelly Martin

    Chief Financial Officer who reported the open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$APOMedAI 8/10

Apollo sees Azerbaijan as key market for energy project financing

Apollo Global Management is discussing financing major energy projects in Azerbaijan, according to Jamshid Ehsani, Head of Global Structured Finance. Ehsani highlighted investment opportunities in critical minerals and energy infrastructure, and noted discussions with the State Oil Company of Azerbaijan (SOCAR). Apollo and SOCAR have already expanded cooperation, with Apollo acquiring a minority stake in TANAP and exploring additional financing of up to $300 million.

$APOMedAI 8/10

APO Looks 0.7% Overvalued on GF Value™ Amid Dividend Sustainabil

Apollo Global Management (APO) faces potential $1.1B losses from the collapse of Market Financial Solutions. Despite this, APO offers a 1.71% dividend yield with a 49% payout ratio and 7.6% 3-year growth. GF Value™ suggests APO is 0.7% overvalued at $124.73. APO's GF Score™ is 77/100, with strong profitability and momentum but weak growth. Insiders and gurus have been selling shares.

$APOLow

Apollo faces as much as $1.1B in loss on MFS collapse - report

Apollo Global Management (APO) may face up to $1.1B in losses due to the collapse of mortgage firm Market Financial Solutions (MFS), according to a Bloomberg report. Two MFS entities owe approximately £970M to Apollo's credit arm, Atlas SP Partners, with potential recovery estimated between £107M and £200M.

$JNJMedAI 8/10

Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal

Johnson & Johnson (JNJ) is considering selling its orthopedics unit, DePuy Synthes, for $20 billion to Apollo Global Management. The move aligns with J&J's strategy to streamline operations and focus on higher-growth, higher-margin businesses. According to the company, this will accelerate its shift toward more profitable markets. The sale could provide J&J with cash for stock buybacks, debt reduction, or reinvestment.

$APOMedAI 8/10

Apollo (APO) Nears a 16% Stake in the Yankees. Why Private Equity Wants a Piece of Baseball

Apollo Global Management (APO) is nearing a deal for a 16% stake in the New York Yankees, valued at over $12 billion. The investment, structured as credit and equity, includes 8% common equity and 8% convertible preferred stock. Apollo aims to leverage sports' stable cash flows and rising franchise values, though concerns include valuation, lack of control, and media rights uncertainty. APO shares are down 12% this year, and the deal is unlikely to significantly impact earnings.